LungLife AI, Inc.

AIM:LLAI Stock Report

Market Cap: UK£2.8m

LungLife AI Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LLAI?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,347,6534.4%
VC/PE Firms3,642,41811.9%
General Public7,399,35424.1%
Individual Insiders8,016,85726.1%
Institutions10,252,32133.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.3%.

Top Shareholders

Top 17 shareholders own 75.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.5%
Simon Raab
4,148,293UK£373.3k0%no data
12.7%
Unicorn Asset Management Ltd.
3,907,142UK£351.6k0%0.06%
8.06%
Mount Sinai School Of Medicine, Endowment Arm
2,469,842UK£222.3k0%0.12%
6.42%
Octopus Investments Limited
1,968,750UK£177.2k0%0.01%
5.46%
Syno Capital
1,673,668UK£150.6k0%no data
4.99%
Frederick Gluck
1,530,596UK£137.8k0%no data
4.65%
Stifel Asset Management Corp.
1,424,784UK£128.2k0%no data
4.55%
Investec Wealth & Investment Limited
1,394,839UK£125.5k0%no data
4.4%
Bohai Ferry Group Co., Ltd.
1,347,653UK£121.3k0%no data
4.14%
Lombard Odier
1,268,363UK£114.2k0%no data
3.11%
Huateng Ma
954,048UK£85.9k0%no data
2.73%
Killik Asset Management
836,964UK£75.3k0%0.01%
0.71%
SVM Asset Management Limited
218,750UK£19.7k0%0.01%
0.14%
Roy Davis
42,775UK£3.8k0%no data
0.086%
David Anderson
26,408UK£2.4k0%no data
0.086%
Paul Pagano
26,408UK£2.4k0%no data
0.065%
Andrew Boteler
19,966UK£1.8k0%no data